SEC Form 4 · accession 0001179110-19-001833
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony M. Manning
Officer — Chief Scientific Officer
Period of report
Feb 11, 2019
Accepted (ET)
Feb 13, 2019 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 12, 2019 | S | 133 | $12.77 | D | 63,167 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F3 | $12.76 | Feb 11, 2019 | A | 106,000 | A | — | Feb 11, 2029 | Common Stock | 106,000 | 106,000 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F2Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
- F3The stock option will vest and become exercisable with respect to 26,500 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. All vesting is subject to Anthony Manning's continued service to the Company through the applicable vesting date.